New discovery offers hope for stopping childhood brain tumors before they start

Revolutionizing Cancer Treatment: A New Dawn for Pediatric Brain Cancer Recent research from The Hospital for Sick Children (SickKids) has brought renewed hope to the fight against pediatric brain cancer. Scientists led by Dr. Peter Dirks have pioneered a groundbreaking method to intercept the growth of SHH medulloblastoma, the most common type of malignant brain … Read more

Staying social may delay dementia by 5 years

The Power of Social Connections in Delaying Dementia Recent findings from the Rush Memory and Aging Project have spotlighted the profound impact of social activity on delaying the onset of dementia by up to five years. This emphasizes the power of social connections in enhancing brain health and offers promising insights for public health strategies. … Read more

USC receives $6 million grant for pioneering glioblastoma gene therapy

Revolutionary Gene Therapy: A New Horizon in Glioblastoma Treatment Glioblastoma, a formidable adversary in the realm of brain cancers, has long defied medical science, boasting a mere 5 percent five-year survival rate. Yet, hope is on the horizon, thanks to a groundbreaking gene therapy pioneered by researchers at the University of Southern California (USC). Recently … Read more

What 48 years of data reveal

The Return of the Egg: Future Trends in Dietary Choices For decades, eggs were cast aside by many due to fears about dietary cholesterol. However, as recent studies indicate, these worries may be based on outdated understandings of nutrition. One pivotal study from the University of California San Diego, published in the journal Nutrients, shows … Read more

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

Revolutionary New Nonaddictive Pain Medication Approved by FDA The FDA has approved a groundbreaking new medication, suzetrigine (sold as Journavx), created by Vertex Pharmaceuticals, marking a significant advancement in pain management. Unlike traditional opioid painkillers, suzetrigine is designed to alleviate pain without the risk of addiction, operating exclusively outside the brain to block pain signals. … Read more

Frequent social engagement may delay dementia onset

Can Socializing Reduce Dementia Risk? New research published in *Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association* highlights the potential benefits of social activities in delaying the onset of dementia. Studies suggest that frequent social engagement may work as a protective factor against cognitive decline in later years. The Power of Stay-In-touch Research conducted … Read more

Alzheimer’s and Parkinson’s linked to aging brain’s failing waste disposal

The Emerging Focus on Protein Clearance in Neurodegenerative Diseases Neurodegenerative diseases such as Alzheimer’s and Parkinson’s have long been shrouded in mystery. Traditionally, these conditions were thought to be primarily genetic. However, a recent shift in scientific research suggests a surprising cause: the failing cleanup systems in our brains. This revelation not only unravels the … Read more

Higher intensity walking program boosts mobility in stroke survivors

The Future of Stroke Rehabilitation: A Focus on Higher-Intensity Walking Revolutionizing Stroke Recovery through Progressive Exercise Recent studies underscore the importance of progressive, high-intensity walking regimens in stroke rehabilitation. A pioneering study presented at the American Stroke Association’s International Stroke Conference in 2025 highlighted that stroke survivors who engaged in higher-intensity walking consistently alongside regular … Read more

Oral and gut bacteria in stroke patients associated with worse prognosis and mortality

The Hidden Connection: Oral and Gut Bacteria’s Role in Stroke Risk In recent groundbreaking research presented at the American Stroke Association’s International Stroke Conference, the potential impact of Streptococcus anginosus on stroke risk has emerged as a significant concern. This bacterium, commonly found in the mouth and gastrointestinal tract, has been linked with worse stroke … Read more

Map highlights diagnosis gaps for deadly CNS infections in HIV patients in Africa

Unveiling Diagnosis Gaps in Africa’s Fight Against HIV-Linked CNS Diseases The interconnection between HIV and other infectious diseases targeting the central nervous system (CNS) is gaining increased attention, with recent research highlighting diagnosis gaps in Africa. This crucial study, published in *The Lancet Global Health*, sheds light on the geographical discrepancies in diagnosis capabilities, emphasizing … Read more